← Back to Search

Supportive Care (narrative medicine sessions) for Gastrointestinal Cancer

N/A
Recruiting
Led By Eve L Makoff, MD
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients with diagnosis of gastrointestinal malignancy actively receiving infusional therapy for cancer
Age >= 18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 months
Awards & highlights

Study Summary

This trial aims to see if using storytelling methods, known as narrative medicine, can help improve the emotional well-being of patients with GI cancer. Narrative medicine involves healthcare providers listening to patients' stories about their

Who is the study for?
This trial is for patients with gastrointestinal cancers. Participants should be interested in exploring narrative medicine, which involves discussion, interviews, and surveys to reflect on their life stories and illness experiences.Check my eligibility
What is being tested?
The study tests if narrative medicine methods like close reading, creative writing, and discussions can improve well-being in GI cancer patients by enhancing communication between them and healthcare providers.See study design
What are the potential side effects?
Since the interventions are non-medical (discussion, interview, survey), there aren't typical side effects as seen with drugs or surgeries. However, participants may experience emotional discomfort when sharing personal stories.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently receiving infusion treatments for gastrointestinal cancer.
Select...
I am 18 years old or older.
Select...
I can take care of myself but cannot do any physical work.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in well-being scores
Number of participants who complete the narrative medicine sessions

Trial Design

1Treatment groups
Experimental Treatment
Group I: Supportive Care (narrative medicine sessions)Experimental Treatment3 Interventions
Patients participate in narrative medicine sessions over 60 minutes Q2W for 3 sessions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Discussion
2021
N/A
~130

Find a Location

Who is running the clinical trial?

University of Southern CaliforniaLead Sponsor
906 Previous Clinical Trials
1,596,212 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,680 Previous Clinical Trials
40,927,295 Total Patients Enrolled
Eve L Makoff, MDPrincipal InvestigatorUniversity of Southern California

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available openings for participants in this ongoing trial?

"As per clinicaltrials.gov, this research study is presently seeking volunteers. It was initially published on September 27th, 2023 and last revised on April 17th, 2024."

Answered by AI

What is the overall count of individuals involved in this research endeavor?

"Indeed, as per the details on clinicaltrials.gov, this particular clinical trial is actively seeking participants. The study was initially listed on September 27th, 2023 and the latest update occurred on April 17th, 2024. Enrollment for this trial is limited to a total of 10 individuals at one designated site."

Answered by AI
~3 spots leftby Sep 2024